| Q52724685 | A Study and Review of Effects of Botulinum Toxins on Mast Cell Dependent and Independent Pruritus. |
| Q42127409 | A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury |
| Q38171394 | An update on botulinum toxin A injections of trigger points for myofascial pain |
| Q37766794 | An update on the neurologic applications of botulinum toxins |
| Q35843970 | Antinociceptive Effects of Transcytosed Botulinum Neurotoxin Type A on Trigeminal Nociception in Rats |
| Q48579779 | Antinociceptive action of botulinum toxin type A in carrageenan-induced mirror pain. |
| Q87090158 | Association of antinociceptive action of botulinum toxin type A with GABA-A receptor |
| Q38750238 | Bilateral analgesic effects of abobotulinumtoxinA (Dysport® ) following unilateral administration in the rat. |
| Q92705676 | Botulinum Neurotoxins and Cancer-A Review of the Literature |
| Q92527863 | Botulinum Toxin a Valuable Prophylactic Agent for Migraines and a Possible Future Option for the Prevention of Hormonal Variations-Triggered Migraines |
| Q28084583 | Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception |
| Q55498097 | Botulinum Toxin for Central Neuropathic Pain. |
| Q26796604 | Botulinum Toxin for Neuropathic Pain: A Review of the Literature |
| Q41669358 | Botulinum Toxin for the Treatment of Neuropathic Pain |
| Q37954278 | Botulinum neurotoxin for pain management: insights from animal models |
| Q38365855 | Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior |
| Q35691221 | Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents |
| Q58700974 | Botulinum toxin type A enhances the inhibitory spontaneous postsynaptic currents on the substantia gelatinosa neurons of the subnucleus caudalis in immature mice |
| Q36780108 | Botulinum toxin type A for neuropathic pain in patients with spinal cord injury |
| Q38944196 | Botulinum toxin type A in motor nervous system: unexplained observations and new challenges. |
| Q34125262 | Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy |
| Q48470000 | Comparison of analgesic effects of single versus repeated injection of botulinum toxin in orofacial formalin test in rats. |
| Q26778129 | Current status and future directions of botulinum neurotoxins for targeting pain processing |
| Q38873658 | Diverse Physiological Roles of Calcitonin Gene-Related Peptide in Migraine Pathology: Modulation of Neuronal-Glial-Immune Cells to Promote Peripheral and Central Sensitization |
| Q89578185 | Effect of Botulinum Toxin A on Bladder Pain-Molecular Evidence and Animal Studies |
| Q37062762 | Effects of intraplantar botulinum toxin-B on carrageenan-induced changes in nociception and spinal phosphorylation of GluA1 and Akt |
| Q53208463 | Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT/A). |
| Q36035614 | Evidence-based knee injections for the management of arthritis |
| Q55012749 | Exploiting Botulinum Neurotoxins for the Study of Brain Physiology and Pathology. |
| Q38484402 | Ganglion impar block with botulinum toxin type a for chronic perineal pain -a case report-. |
| Q36507209 | Incobotulinum Toxin-A Improves Post-Surgical and Post-Radiation Pain in Cancer Patients. |
| Q35837340 | Insights into the mechanism of onabotulinumtoxinA in chronic migraine |
| Q54357961 | Intrathecal administration of botulinum toxin type A improves urinary bladder function and reduces pain in rats with cystitis. |
| Q92455068 | Mechanisms of Botulinum Toxin Type A Action on Pain |
| Q36317697 | None detectable retrograde transport of Chinese botulinum toxin type A in mice by single intramuscular injection |
| Q28087509 | Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection |
| Q89522662 | Pain |
| Q34460791 | The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes |
| Q34419654 | Therapeutic use of botulinum toxin in migraine: mechanisms of action |
| Q97884829 | Therapeutic use of botulinum toxin in pain treatment |
| Q90839013 | Treatment of at-level spinal cord injury pain with botulinum toxin A |
| Q26773579 | Treatment of painful bladder syndrome/interstitial cystitis with botulinum toxin A: why isn't it effective in all patients? |
| Q83971850 | [Effect of botulinum toxin type B on residual limb sweating and pain. Is there a chance for indirect phantom pain reduction by improved prosthesis use?] |